Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept vs Tacrolimus in Deceased Donor Renal Transplant
NCT02152345Phase 4Completed
- Sponsor
- Columbia University
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of belatacept in kidney transplant rejection (2 arms), sponsored by Columbia University. Primary endpoint: Delayed Graft Function at 3 months. Started Jun 2014; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02152345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02152345.